GEHC — tear sheet

The engine assesses GE HealthCare as Overweight, leaning on the dated filings in the corpus. Management's 8-K Item 2.02 press release (2026-07-23) reported preliminary Q2 2026 revenue growth of 5.7% year over year, organic growth of 3.5%, adjusted EPS ahead of prior expectation, and reaffirmed full-year 2026 guidance, issued alongside a CFO transition the engine characterizes as voluntary. Per the quantorb 13F dataset (as of 2026-03-31), five tracked filers netted roughly +8.2 million shares, about 40% quarter over quarter, led by Barrow Hanley at +82.7% and Hotchkis & Wiley at +10.4%. The 10-K (filed 2026-02-04) describes a franchise serving customers in over 160 countries. The QuantOrb snapshot (2026-09-17) shows MFI 20.73 with a BUY screen signal at 0.7668 strength, labeled a screen output, not a recommendation. The engine notes price, valuation and news data are not available in provided documents and conditions further conviction on the permanent CFO outcome and the Q3 print. Sources: [EIGHTK]; [THIRTEENF]; [FILING]; [FACTS]

Source: SEC 13F-HR holdings (as of 2026-03-31) via quantorb filers data — quarter-end snapshots, statutory lag up to 45 days

Quarter-end 13F-HR snapshot for GEHC as tracked in the quantorb filers dataset (5 institutional filer rows on file; positions as of 2026-03-31, a quarter-end snapshot subject to the statutory 13F reporting lag of up to 45 days). Quarter-over-quarter share changes where the dataset carries them:

This is the dataset's tracked top-holder snapshot, not an exhaustive list of 13F filers; it is a periodic regulatory disclosure, not real-time portfolio data.

Management's disclosure on record is the 8-K Item 2.02 press release of 2026-07-23. It announces CFO Jay Saccaro stepping down for an expanded role outside the medical technology industry, remaining through August 14, 2026, with George Newcomb, currently Controller and Chief Accounting Officer with more than 38 years of finance leadership, appointed interim CFO and a permanent-successor search commenced. CEO Peter Arduini credited Saccaro with financial discipline and strategic investments over three years. The release states preliminary second-quarter 2026 results reflect business momentum: revenue growth of 5.7% year over year, organic revenue growth of 3.5%, adjusted EPS performance ahead of prior expectation, and reaffirms full-year 2026 guidance. The 10-K (filed 2026-02-04) carries forward-looking-statement language noting results are subject to uncertainty. Catalysts in the corpus: the permanent CFO search, the Q3 2026 report (date not available in provided documents), and any new 8-K or guidance-language change, which the engine flags for same-day review. Sources: [EIGHTK]; [FILING]

The engine's risk review flags selling pressure first: the QuantOrb snapshot (2026-09-17) shows MFI 20.73, which the conservative seat notes can persist in a downtrend, and trend context cannot be checked because price data is not available in provided documents. Holdings evidence is stale and narrow: the quantorb 13F dataset is a quarter-end snapshot as of 2026-03-31 with a statutory lag of up to 45 days, five tracked filer rows, not exhaustive, and the engine cautions that Mizuho Markets Cayman's +173.2% add may be trading inventory rather than conviction. Governance risk: the CFO seat has been interim since August 14, 2026, and the engine calls the vacancy a binary event that can gap either way. Coverage gaps: news, social, macro and price pulls returned no data; no final Q2 10-Q is in the corpus. The engine states it would reassess toward Hold/Underweight if Q3 organic growth slips materially below 3.5%. Sources: [FACTS]; [EIGHTK]; [THIRTEENF]